Korro Announces $70 Million Private Placement
Korro to Participate in Upcoming Investor Conferences
Korro Reports Full Year 2023 Financial Results and Highlights Recent Progress
Korro Bio Raises $116 Million for RNA Editing Program
Korro Bio sings to the tune of $116M for its OPERA RNA editing program
RNA-editing startup to double headcount with $116M in new VC
Development of a selection assay for small guide RNAs that drive efficient site-directed RNA editing